162 related articles for article (PubMed ID: 29621567)
1. Salivary biomarkers of inflammation in systemic lupus erythematosus.
Stanescu II; Calenic B; Dima A; Gugoasa LA; Balanescu E; Stefan-van Staden RI; Baicus C; Badita DG; Greabu M
Ann Anat; 2018 Sep; 219():89-93. PubMed ID: 29621567
[TBL] [Abstract][Full Text] [Related]
2. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
[TBL] [Abstract][Full Text] [Related]
3. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
4. Salivary levels of inflammatory cytokines and their association to periodontal disease in systemic lupus erythematosus patients. A case-control study.
Marques CP; Victor EC; Franco MM; Fernandes JM; Maor Y; de Andrade MS; Rodrigues VP; Benatti BB
Cytokine; 2016 Sep; 85():165-70. PubMed ID: 27371775
[TBL] [Abstract][Full Text] [Related]
5. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
Živković V; Cvetković T; Mitić B; Stamenković B; Stojanović S; Radovanović-Dinić B; Jurišić V
Rheumatol Int; 2018 Jun; 38(6):1003-1008. PubMed ID: 29181621
[TBL] [Abstract][Full Text] [Related]
6. The salivary levels of leptin and interleukin-6 as potential inflammatory markers in children obesity.
Pîrsean C; Neguț C; Stefan-van Staden RI; Dinu-Pirvu CE; Armean P; Udeanu DI
PLoS One; 2019; 14(1):e0210288. PubMed ID: 30605486
[TBL] [Abstract][Full Text] [Related]
7. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B
Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
9. Salivary Cytokines as Potential Diagnostic Biomarkers for Systemic Lupus Erythematosus Disease.
Zian Z; Bouhoudan A; Mourabit N; Azizi G; Bennani Mechita M
Mediators Inflamm; 2021; 2021():8847557. PubMed ID: 33776578
[TBL] [Abstract][Full Text] [Related]
10. Whole saliva in systemic lupus erythematosus patients.
Ben-Aryeh H; Gordon N; Szargel R; Toubi E; Laufer D
Oral Surg Oral Med Oral Pathol; 1993 Jun; 75(6):696-9. PubMed ID: 7685874
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus.
Ruacho G; Lira-Junior R; Gunnarsson I; Svenungsson E; Boström EA
Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35246487
[TBL] [Abstract][Full Text] [Related]
12. Leptin and NGF in saliva of patients with diabetes mellitus type 2: A pilot study.
Tvarijonaviciute A; Castillo C; Ceron JJ; Martinez-Subiela S; Tecles F; López-Jornet P
J Oral Pathol Med; 2017 Oct; 46(9):853-855. PubMed ID: 28437012
[TBL] [Abstract][Full Text] [Related]
13. Salivary proteomics: A new adjuvant approach to the early diagnosis of familial juvenile systemic lupus erythematosus.
Abrão AL; Falcao DP; de Amorim RF; Bezerra AC; Pombeiro GA; Guimarães LJ; Fregni F; Silva LP; da Mota LM
Med Hypotheses; 2016 Apr; 89():97-100. PubMed ID: 26968919
[TBL] [Abstract][Full Text] [Related]
14. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.
Bauer JW; Petri M; Batliwalla FM; Koeuth T; Wilson J; Slattery C; Panoskaltsis-Mortari A; Gregersen PK; Behrens TW; Baechler EC
Arthritis Rheum; 2009 Oct; 60(10):3098-107. PubMed ID: 19790071
[TBL] [Abstract][Full Text] [Related]
15. Nonenzymatic antioxidants in saliva of patients with systemic lupus erythematosus.
Moori M; Ghafoori H; Sariri R
Lupus; 2016 Mar; 25(3):265-71. PubMed ID: 26449364
[TBL] [Abstract][Full Text] [Related]
16. Physical Fitness Attenuates the Impact of Higher Body Mass and Adiposity on Inflammation in Women With Systemic Lupus Erythematosus.
Sola-Rodríguez S; Vargas-Hitos JA; Gavilán-Carrera B; Rosales-Castillo A; Ríos-Fernández R; Sabio JM; Soriano-Maldonado A
Front Immunol; 2021; 12():729672. PubMed ID: 34721392
[TBL] [Abstract][Full Text] [Related]
17. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.
Chun HY; Chung JW; Kim HA; Yun JM; Jeon JY; Ye YM; Kim SH; Park HS; Suh CH
J Clin Immunol; 2007 Sep; 27(5):461-6. PubMed ID: 17587156
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
19. Role for leptin and prolactin in human juvenile rheumatic diseases.
Elwakkad AS; Said RN; Muhammad SI; Saleh MT; Elhamshary A
Pak J Biol Sci; 2007 Jun; 10(12):1984-9. PubMed ID: 19093436
[TBL] [Abstract][Full Text] [Related]
20. Associations between serum interleukin-23 levels and clinical characteristics in patients with systemic lupus erythematosus.
Du J; Li Z; Shi J; Bi L
J Int Med Res; 2014 Oct; 42(5):1123-30. PubMed ID: 24990863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
